Inflammation and oxidative stress as biomarkers of premature aging in persons with intellectual disability

Research in Developmental Disabilities

Volumn 33, Issue 2, 2012, Pages 369-375

  Carmeli, Eli ^a   Imam, Bita ^b   Bachar, Asad ^c   Merrick, Joav ^d  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Neve Ram Residential Care Center   (Israel)

^d DIVISION FOR INTELLECTUAL AND DEVELOPMENTAL DISABILITIES   (Israel)

Author keywords

Aging; Inflammation; Intellectual disability; Interleukin; Nitric oxide; Oxidative stress

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 6; NITRIC OXIDE;

ADULT; ARTICLE; BLOOD ANALYSIS; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; INTELLECTUAL IMPAIRMENT; MALE; OXIDATIVE STRESS; PREMATURE AGING; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGING, PREMATURE; BIOLOGICAL MARKERS; FEMALE; HUMANS; INFLAMMATION; INTELLECTUAL DISABILITY; INTERLEUKIN-1ALPHA; INTERLEUKIN-6; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS;

EID: 82055165282     PISSN: 08914222     EISSN: 18733379     Source Type: Journal    
DOI: 10.1016/j.ridd.2011.10.002     Document Type: Article

References (34)

1. Batty G.D., Deary I.J., Gottfredson L.S. Premorbid (early life) IQ and later mortality risk: Systematic review. Annals of Epidemiology 2006, 17:278-288.
2. Bayir H., Kagan V.E. Bench-to-bedside review: Mitochondrial injury, oxidative stress and apoptosis-There is nothing more practical than a good theory. Critical Care 2008, 12:206-207.
3. Bujak M., Frangogiannis N.G. The role of IL-1 in the pathogenesis of heart disease. Archivum Immunologiae et Therapiae Experimentalis (Warsz) 2009, 57:165-176.
4. Carmeli E., Fogelman Y. Antioxidant effect of polyphenolic glabridin on LDL oxidation. Toxicology and Industrial Health 2009, 25:321-324.
5. Cataldi A. Cell responses to oxidative stressors. Current Pharmaceutical Design 2010, 16:1387-1395.
6. Dinarello C.A. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. The American Journal of Clinical Nutrition 2009, 83:447S-455S.
7. Epel E.S. Psychological and metabolic stress: A recipe for accelerated cellular aging. Hormones (Athens) 2009, 8:7-22.
8. Estrov Z., Kurzrock R., Talpaz M. Interleukin-1 and its inhibitors: Implications for disease biology and therapy. Cancer Treatment and Research 1995, 80:51-82.
9. Finlayson M.L., Peterson E.W. Falls, aging, and disability. Physical Medicine and Rehabilitation Clinics of North America 2010, 21:357-373.
10. Flirski M., Sobow T. Biochemical markers and risk factors of Alzheimer's disease. Current Alzheimer Research 2005, 2:47-64.
11. Fritzenwanger M., Meusel K., Foerster M., Kuethe F., Krack A., Figulla H.R. Cardiotrophin-1 induces interleukin-6 synthesis in human monocytes. Cytokine 2007, 38:137-144.
12. Chen X., Qian X., Chen H., Dong M. Serum levels of nitric oxide metabolites during labour with or without combined spinal-epidural analgesia. European Journal of Anaesthesiology 2008, 25:708-713.
13. Fulop T., Larbi A., Douziech N., Levesque I., Varin A., Herbein G. Cytokine receptor signaling and aging. Mechanisms of Ageing and Development 2006, 127:526-537.
14. Glade M.J. Oxidative stress and cognitive longevity. Nutrition 2010, 26:595-603.
15. Gonzalez R.M., Seurynck-Servoss S.L., Crowley S.A., Brown M., Omenn G.S., Hayes D.F., et al. Development and validation of sandwich ELISA microarrays with minimal assay interference. Journal of Proteome Research 2008, 7:2406-2414.
16. Harman D. Aging: A theory based on free radical and radiation chemistry. Journal of Gerontology 1956, 11:298-300.
17. Janicki M.P., Dalton A.J., Henderson C.M., Davidson P.W. Mortality and morbidity among older adults with intellectual disability: Health services considerations. Disability and Rehabilitation 1999, 21:284-294.
18. Jylhävä J., Hurme M. Gene variants as determinants of longevity: Focus on the inflammatory factors. Pflugers Archiv: European Journal of Physiology 2010, 459:239-246.
19. Kilgour A.H., Starr J.M., Whalley L.J. Associations between childhood intelligence (IQ), adult morbidity and mortality. Maturitas 2010, 65:98-105.
20. Levers M.J., Estabrooks C.A., Ross-Kerr J.C. Factors contributing to frailty: Literature review. Journal of Advanced Nursing 2006, 56:282-291.
21. Lin J.D., Wu C.L., Lin P.Y., Lin L.P., Chu C.M. Early onset ageing and service preparation in people with intellectual disabilities: Institutional managers' perspective. Research in Developmental Disabilities 2011, 32:188-193.
22. Luiking Y.C., Engelen M.P., Deutz N.E. Regulation of nitric oxide production in health and disease. Current Opinion in Clinical Nutrition and Metabolic Care 2010, 13:97-104.
23. McCann S.M., Licinio J., Wong M.L., Yu W.H., Karanth S., Rettorri V. The nitric oxide hypothesis of aging. Experimental Gerontology 1998, 33:813-826.
24. Michel T., Vanhoutte P.M. Cellular signaling and NO production. Pflugers Archiv: European Journal of Physiology 2010, 459:807-816.
25. Obrenovich M.E., Li Y., Parvathaneni K., Yendluri B.B., Palacios H.H., Leszek J., et al. Antioxidants in health, disease and aging. CNS & Neurological Disorders Drug Targets 2011, 10:192-207.
26. Odrowaz-Sypniewska G. Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome. Advances in Medical Sciences 2007, 52:246-250.
27. Oliveira B.F., Nogueira-Machado J.A., Chaves M.M. The role of oxidative stress in the aging process. TheScientificWorldJournal 2010, 10:1121-1128.
28. Olshansky S.J. The law of mortality revisited: Interspecies comparisons of mortality. Journal of Comparative Pathology 2010, 142:S4-S9.
29. Roth G.M., Sun B., Greensite F.S., Lott I.T., Dietrich R.B. Premature aging in persons with Down syndrome: MR findings. American Journal of Neuroradiology 1996, 17:1283-1289.
30. Torr J., Davis R. Ageing and mental health problems in people with intellectual disability. Current Opinion in Psychiatry 2007, 20:467-471.
31. Wanderer A.A. Ischemic-reperfusion syndromes: Biochemical and immunologic rationale for IL-1 targeted therapy. Clinical Immunology 2008, 128:127-132.
32. Wolfson L. Gait and balance dysfunction: A model of the interaction of age and disease. Neuroscientist 2001, 7:178-183.
33. Wu T.L., Chang P.Y., Tsao K.C., Sun C.F., Wu L.L., Wu J.T. A panel of multiple markers associated with chronic systemic inflammation and the risk of atherogenesis is detectable in asthma and chronic obstructive pulmonary disease. Journal of Clinical Laboratory Analysis 2007, 21:367-371.
34. Yoo J.H., Maeng H.Y., Sun Y.K., Kim Y.A., Park D.W., Park T.S., et al. Oxidative status in iron-deficiency anemia. Journal of Clinical Laboratory Analysis 2009, 23:319-323.